Pharmac have announced they will fully fund the breast cancer drug palbociclib (Ibrance) for all patients with the disease.
Pfizer is the supplier of the breast cancer drug. Photo: AFP
Access for the life-extending drug will become available to all patients⦠[+3127 chars]Source
